D-0622-2020 Class II Terminated

Recalled by Medisca, Inc. — Plattsburgh, NY

FDA drug recall D-0622-2020 was initiated by Medisca, Inc. on Nov 25, 2019 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications The recall status is terminated (terminated Mar 17, 2021). Affected quantity: 640,325 grams.

Recall details

Product Type
Drugs
Report Date
Dec 25, 2019
Initiation Date
Nov 25, 2019
Termination Date
Mar 17, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
640,325 grams

Product description

Estriol, USP (Micronized) 1 g, 5 g, 25 g, 100 g, 2000 g, 1 kg, containers, Packed by Medisca Inc., Plattsburgh, NY 12901, USA

Reason for recall

Failed Impurities/Degradation Specifications

Distribution pattern

Nationwide

Code information

Lot #156110 A-P Lot #153328 A-D Lot #161726 A-L

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0622-2020
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0622-2020. Report a data issue: hello@regdatalab.com.